Skip Content
You are currently on the new version of our website. Access the old version .

Vaccines, Volume 5, Issue 1

2017 March - 8 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (8)

  • Article
  • Open Access
16 Citations
6,784 Views
8 Pages

Prior research indicates that cost-sharing and lack of insurance coverage reduce preventive services use among low-income persons. State Medicaid policy may affect the uptake of recommended adult vaccinations. We examined the impact of three aspects...

  • Review
  • Open Access
72 Citations
9,456 Views
10 Pages

The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture

  • Federico Garrido,
  • Francisco Perea,
  • Mónica Bernal,
  • Abel Sánchez-Palencia,
  • Natalia Aptsiauri and
  • Francisco Ruiz-Cabello

27 February 2017

Tumor immune escape is associated with the loss of tumor HLA class I (HLA-I) expression commonly found in malignant cells. Accumulating evidence suggests that the efficacy of immunotherapy depends on the expression levels of HLA class I molecules on...

  • Review
  • Open Access
145 Citations
11,385 Views
15 Pages

Harnessing Nanoparticles for Immunomodulation and Vaccines

  • Ariane C. Gomes,
  • Mona Mohsen and
  • Martin F. Bachmann

14 February 2017

The first successful use of nanoparticles (NPs) for vaccination was reported almost 40 years ago with a virus-like particle-based vaccine against Hepatitis B. Since then, the term NP has been expanded to accommodate a large number of novel nano-sized...

  • Review
  • Open Access
59 Citations
11,806 Views
12 Pages

Human T Cell Memory: A Dynamic View

  • Derek C. Macallan,
  • José A. M. Borghans and
  • Becca Asquith

4 February 2017

Long-term T cell-mediated protection depends upon the formation of a pool of memory cells to protect against future pathogen challenge. In this review we argue that looking at T cell memory from a dynamic viewpoint can help in understanding how memor...

  • Review
  • Open Access
12 Citations
9,164 Views
21 Pages

From Immunologically Archaic to Neoteric Glycovaccines

  • Marco Cavallari and
  • Gennaro De Libero

27 January 2017

Polysaccharides (PS) are present in the outermost surface of bacteria and readily come in contact with immune cells. They interact with specific antibodies, which in turn confer protection from infections. Vaccines with PS from pneumococci, meningoco...

  • Article
  • Open Access
29 Citations
7,739 Views
17 Pages

A Protective Vaccine against Chlamydia Genital Infection Using Vault Nanoparticles without an Added Adjuvant

  • Janina Jiang,
  • Guangchao Liu,
  • Valerie A. Kickhoefer,
  • Leonard H. Rome,
  • Lin-Xi Li,
  • Stephen J. McSorley and
  • Kathleen A. Kelly

19 January 2017

Chlamydia trachomatis genital infection is the most common sexually transmitted bacterial disease, causing a significant burden to females due to reproductive dysfunction. Intensive screening and antibiotic treatment are unable to completely prevent...

  • Article
  • Open Access
22 Citations
7,609 Views
9 Pages

Young Hungarian Students’ Knowledge about HPV and Their Attitude Toward HPV Vaccination

  • Bettina Claudia Balla,
  • András Terebessy,
  • Emese Tóth and
  • Péter Balázs

29 December 2016

(1) Background: Hungarys’s estimated cervical cancer mortality was 6.9/100,000 in 2012, above the average of the EU27 countries (3.7/100,000) in the same year. Since 2014, the bivalent HPV vaccine has been offered to schoolgirls aged 12–13. (2) Metho...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X